GENETIC TECHNOLOGIES LTD (GENE)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$2.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | $2.0K | 2,650 | 0.00% | 11q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $2.0K | 2,650 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $2.0K | 2,650 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $2.0K | 2,650 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $2.0K | 2,650 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 1 | $2.6K | 3,340 | 0 | 0 | 1 | 0.0% |
| Q1 2025 | 1 | $697 | 3,739 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $2.9K | 3,739 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 10 | $99.6K | 90,273 | 5 | 2 | 1 | 30.6% |
| Q2 2024 | 6 | $377.2K | 252,031 | 1 | 2 | 1 | 0.0% |
| Q1 2024 | 6 | $290.5K | 100,521 | 2 | 1 | 1 | 0.0% |
| Q4 2023 | 6 | $101.0K | 41,841 | 6 | 0 | 0 | 0.5% |
| Q3 2023 | 7 | $103.2K | 134,913 | 0 | 1 | 1 | 0.1% |
| Q2 2023 | 10 | $115.0K | 137,992 | 4 | 1 | 2 | 0.2% |
| Q1 2023 | 9 | $203.7K | 166,421 | 3 | 1 | 2 | 5.2% |
| Q4 2022 | 9 | $241.9K | 221,782 | 1 | 3 | 1 | 15.4% |
| Q3 2022 | 9 | $294.3K | 157,761 | 1 | 1 | 3 | 36.7% |
| Q2 2022 | 13 | $303.3K | 221,075 | 5 | 5 | 0 | 16.2% |
| Q1 2022 | 12 | $792.9K | 134,093 | 3 | 1 | 5 | 66.6% |
| Q4 2021 | 13 | $1.2M | 245,410 | 6 | 3 | 3 | 62.6% |
| Q3 2021 | 10 | $1.7M | 228,837 | 3 | 1 | 3 | 56.1% |
| Q2 2021 | 14 | $2.9M | 350,655 | 2 | 4 | 5 | 48.1% |
| Q1 2021 | 17 | $2.5M | 408,756 | 4 | 6 | 2 | 33.0% |
| Q4 2020 | 13 | $2.2M | 323,942 | 5 | 4 | 1 | 47.6% |
| Q3 2020 | 12 | $1.1M | 188,818 | 8 | 2 | 1 | 38.1% |
| Q2 2020 | 10 | $492.0K | 216,622 | 6 | 0 | 1 | 0.0% |
| Q1 2020 | 4 | $324.0K | 164,948 | 0 | 1 | 1 | 0.0% |
| Q4 2019 | 5 | $263.0K | 132,982 | 1 | 1 | 1 | 0.0% |
| Q3 2019 | 5 | $223.1K | 117,596 | 5 | 0 | 0 | 0.0% |
| Q2 2019 | 10 | $351.0K | 594,442 | 3 | 3 | 1 | 0.0% |
| Q1 2019 | 8 | $607.1K | 684,206 | 0 | 2 | 2 | 0.0% |
| Q4 2018 | 9 | $342.3K | 629,314 | 1 | 0 | 0 | 0.0% |